HUTCHMED Initiates Phase I Trial of Menin Inhibitor HMPL-506 in Patients with Hematological Malignancies in China tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Updated subgroup efficacy and quality of life data were also presented on June 1 at ASCO 2024HONG KONG and SHANGHAI and FLORHAM PARK, N.J., June 03, 2024 HUTCHMED Limited today announces that.
HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., May 23, 2024 HUTCHMED Limited today announces that new and updated data from several studies of compounds discovered by HUTCHMED will be.
HUTCHMED Highlights Presentations at the 2024 ASCO Annual globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.